ContractAgreement • January 13th, 2015 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Confidential treatment has been requested for certain portions of this exhibit pursuant to a request for confidential treatment under Rule 24b-2 of the Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Confidential portions are marked: [***].
